PODD logo

PODD Insulet Corp.

NASDAQ · Medical - Devices · Healthcare

$133.17
-4.06 (-2.96%)

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain …

Market Cap: $9.24Bwww.insulet.com

Price

$143.34-50.46%
$133.26$206.45$279.63$352.82
Jul 2025Aug 2026

Social Signal Score

65
5d
70
1 mentions
+0.0%
30d
65
6 mentions
+0.0%
60d
63
13 mentions
+0.0%
90d
61
23 mentions
+0.0%
news: 17 · rss: 6

Analyst Ratings

50 analysts
Buyconsensus
Strong Buy 0Buy 28Hold 20Sell 2Strong Sell 0
Avg price target$177.41+33.2%
Low $144Median $175High $235
Current Consensus

52-week range

$133.26$352.82
Last close
$143.34
Off 52w high
-59.4%
200-day average
$223.41
vs 200-day
-35.8%

Compare with other stocks off their highs

Revenue

$842.00M+712.94%
$101.71M$348.48M$595.24M$842.00M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$4.88
$4.72–$5.23
16 analysts
FY2026
$6.81+39% YoY
$6.76–$6.86
14 analysts
FY2027
$8.01+18% YoY
$7.78–$8.25
15 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Ashley McEvoy
Sector
Healthcare
Industry
Medical - Devices
Employees
5,400
Beta
1.06
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
5.22
www.insulet.com